Vaccine efficacy trials for human immunodeficiency virus/acquired immunodeficiency syndrome are feasible in the United States: a commentary on the HIVNET Vaccine Preparedness Study.
School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294-2170, USA. sten@uab.edu
S H
SH
Vermund
D016915:AIDS Vaccines / Q000008:administration & dosage*; D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks / Q000517:prevention & control*; D005240:Feasibility Studies; D015658:HIV Infections / Q000453:epidemiology*; D006801:Humans; D018579:Patient Selection; D012680:Sensitivity and Specificity; D014481:United States / Q000453:epidemiology
D016915:AIDS Vaccines